{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T18:14:52Z","timestamp":1787681692936,"version":"build-2784847793"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 111\\u20132410-H-038-001-MY2"],"award-info":[{"award-number":["NSTC 111\\u20132410-H-038-001-MY2"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.vaccine.2025.126830","type":"journal-article","created":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T22:42:10Z","timestamp":1740955330000},"page":"126830","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Comparative analysis of fourteen COVID-19 vaccine injury compensation systems and claim approval rates"],"prefix":"10.1016","volume":"52","author":[{"given":"Chao-Fang","family":"Chu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzu-Hao","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jen-Ji","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2025.126830_bb0005","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/S0264-410X(99)00291-1","article-title":"Vaccine injury compensation programs worldwide","volume":"17","author":"Evans","year":"1999","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2025.126830_bb0010","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2471\/BLT.10.081901","article-title":"No-fault compensation following adverse events attributed to vaccination: a review of international programmes","volume":"89","author":"Looker","year":"2011","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2025.126830_bb0015","doi-asserted-by":"crossref","first-page":"652","DOI":"10.12688\/f1000research.51160.2","article-title":"Current situation of vaccine injury compensation program and a future perspective in light of COVID-19 and emerging viral diseases","volume":"10","author":"Crum","year":"2021","journal-title":"F1000Res"},{"issue":"13","key":"10.1016\/j.vaccine.2025.126830_bb0020","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2024.39.e121","article-title":"COVID-19 vaccine injury compensation program: lessons learned from a review of 10 implementing countries","volume":"39","author":"Kang","year":"2024","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.vaccine.2025.126830_bb0025","series-title":"Centre for Socio-Legal Studies. Global Summary: Covid-19 Vaccine No Fault Compensation Schemes","year":"2023"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126830_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.26855\/ijcemr.2021.01.001","article-title":"Vaccination adverse outcomes and costs of vaccine injury claims (VICs): past, present and Covid-19","volume":"5","author":"Paull","year":"2021","journal-title":"Int J Clin Experimental Med Res"},{"issue":"10","key":"10.1016\/j.vaccine.2025.126830_bb0035","article-title":"\u201cFirst Do No Harm\u201d. No-Fault Compensation Program for COVID-19 Vaccines as Feasibility and Wisdom of a Policy Instrument to Mitigate Vaccine Hesitancy","volume":"9","author":"D\u2019Errico","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126830_bb0040","first-page":"75","article-title":"Comparing no-fault compensation systems for vaccine injury Tul","volume":"31","author":"Fairgrieve","year":"2023","journal-title":"J Int\u2019l & Comp L"},{"key":"10.1016\/j.vaccine.2025.126830_bb0055","unstructured":"Centre for Health Protection, Department of Health The Government of the Hong Kong Special Administrative Region. AEFI Fund Application Overview. updated January 26, 2025. Available from: https:\/\/www.chp.gov.hk\/files\/pdf\/aefi_fund_overview_eng.pdf."},{"key":"10.1016\/j.vaccine.2025.126830_bb0080","unstructured":"Korea Disease Control and Prevention Agency. \uac10\uc5fc\ubcd1 \uc720\ud589\uc73c\ub85c\ubd80\ud130 \uad6d\ubbfc \uac74\uac15 \uc548\uc804\ud558\uac8c [Keeping the National Health Safe from Infectious Disease Outbreaks] 12.8 Briefing Press Release, 2023. Available from: https:\/\/kdca.go.kr\/board\/board.es?mid=a20501010000&bid=0015&list_no=724031&cg_code=&act=view&nPage=6&newsField=202312 [In Korean]."},{"key":"10.1016\/j.vaccine.2025.126830_bb0090","unstructured":"\u885b\u751f\u798f\u5229\u90e8. \u52a0\u901fCOVID-19\u75ab\u82d7\u9810\u9632\u63a5\u7a2e\u53d7\u5bb3\u6551\u6fdf\u884c\u653f\u4f5c\u696d(\u66f8\u9762\u5831\u544a) [Ministry of Health and Welfare. Accelerating Administrative Procedures for COVID-19 Vaccine Injury Compensation (Written Report)] June 28 [In Chinese]."},{"key":"10.1016\/j.vaccine.2025.126830_bb0110","author":"Gwynne"},{"key":"10.1016\/j.vaccine.2025.126830_bb0120","author":"Gouvernement du"},{"key":"10.1016\/j.vaccine.2025.126830_bb0125","unstructured":"Centre for Health Protection, Department of Health The Government of the Hong Kong Special Administrative Region. Indemnity Fund for Adverse Events Following Immunization with Coronavirus Disease-2019 Vaccines. updated October 31, 2024. Available from: https:\/\/www.chp.gov.hk\/en\/features\/107104.html."},{"key":"10.1016\/j.vaccine.2025.126830_bb0130","unstructured":"Korea Disease Control and Prevention Agency. Guideline for Response to Adverse Events Following Immunization, 2022."},{"issue":"2","key":"10.1016\/j.vaccine.2025.126830_bb0135","first-page":"689","article-title":"The prep act and the countermeasures injury compensation program: past, present, and future","volume":"71","author":"Whelan","year":"2022","journal-title":"DePaul L Rev"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126830_bb0140","doi-asserted-by":"crossref","DOI":"10.1093\/jlb\/lsac008","article-title":"Reforming the countermeasures injury compensation program for COVID-19 and beyond: an economic perspective","volume":"9","author":"Zhao","year":"2022","journal-title":"J Law Biosci"},{"issue":"4","key":"10.1016\/j.vaccine.2025.126830_bb0150","doi-asserted-by":"crossref","first-page":"467","DOI":"10.54648\/ERPL2018034","article-title":"Compensation for drug-related injuries","volume":"26","author":"Urho","year":"2018","journal-title":"European Review of Private Law"},{"key":"10.1016\/j.vaccine.2025.126830_bb0160","series-title":"Ministry of Health and Welfare. Article 13 of the Regulations Governing Collection and Review of Vaccine Injury Compensation Fund","year":"2023"},{"key":"10.1016\/j.vaccine.2025.126830_bb0165","series-title":"U.S.C. 247d-6e","year":"2025"},{"issue":"4","key":"10.1016\/j.vaccine.2025.126830_bb0185","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1017\/lst.2022.9","article-title":"Vaccine damage schemes in the US and UK reappraised: making them fit for purpose in light of COVID-19","volume":"42","author":"Goldberg","year":"2022","journal-title":"Leg Stud"},{"issue":"2","key":"10.1016\/j.vaccine.2025.126830_bb0190","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1056\/NEJMp2402379","article-title":"Funding Postauthorization vaccine-safety science","volume":"391","author":"Salmon","year":"2024","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.vaccine.2025.126830_bb0195","article-title":"Acute disseminated encephalomyelitis (ADEM)-like illness in a pediatric patient following COVID-19 vaccination","volume":"9","author":"Brock","year":"2023","journal-title":"BJR Case Rep"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126830_bb0200","article-title":"Post Moderna vaccine associated acute disseminated Encepahlomyelitis (Adem) - a case report. Pakistan","volume":"17","author":"Dr. Sajid","year":"2022","journal-title":"J Neurol Sci"},{"issue":"9","key":"10.1016\/j.vaccine.2025.126830_bb0205","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1016\/j.vaccine.2024.01.100","article-title":"COVID-19 vaccines and adverse events of special interest: a multinational global vaccine data network (GVDN) cohort study of 99 million vaccinated individuals","volume":"42","author":"Faksova","year":"2024","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2025.126830_bb0220","doi-asserted-by":"crossref","first-page":"81","DOI":"10.46754\/umtjur.v5i2.412","article-title":"Vaccine injury compensation mechanism for adverse events caused by COVID-19 vaccines in southeast ASIAN countries","volume":"5","author":"Mustaffa","year":"2023","journal-title":"Universiti Malaysia Terengganu J Undergraduate Res"},{"key":"10.1016\/j.vaccine.2025.126830_bb0225","series-title":"Covid-19: over RM2.5mil paid to 150 people who suffered serious side effects to vaccine, says Dr Zaliha. Star","author":"Rahim","year":"2023"},{"key":"10.1016\/j.vaccine.2025.126830_bb0230","author":"Karolina"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25001276?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25001276?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T08:21:10Z","timestamp":1777537270000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25001276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":28,"alternative-id":["S0264410X25001276"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.126830","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative analysis of fourteen COVID-19 vaccine injury compensation systems and claim approval rates","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.126830","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"126830"}}